Department of Radionuclide Imaging and Therapy
Radionuclide diagnostics and therapy using radiopharmaceuticals
The Scientific and Clinical Department of Radionuclide Diagnostics and Therapy with open-air beds for treatment with radiopharmaceuticals* is a comprehensive unit, as it includes a diagnostic unit (two gamma cameras, equipment for radioimmune “in vitro” studies and a portable gamma counter for intraoperative studies), as well as an inpatient unit for radioiodine therapy of thyroid cancer, treatment of bone metastases and neuroendocrine tumors.
The department is technically equipped to perform diagnostic scans in the “whole body” mode and has a full set of equipment for obtaining radiopharmaceuticals used for diagnostic and therapeutic purposes.
* Radiopharmaceuticals are special medicines that contain a small amount of radioactive substance. They are used in medicine for two main purposes: diagnostics (the drug is injected into the body, it accumulates in a certain organ or tissue, and with the help of special equipment, doctors “see” how this organ works, whether there is a tumor or other changes) and treatment (the radioactive substance acts directly on tumor cells, destroying them and minimally affecting healthy tissues).
Diseases and conditions in which the department specializes
- Thyroid cancer (papillary, follicular, mixed), neuroendocrine tumor – medullary cancer.
- Treatment of bone metastases of various origins. Diagnostic examinations (bones, kidneys, lymph nodes, thyroid gland), diagnostic observations.
Our Doctors and Specialists
Our Doctors and Specialists
The patient must have a discharge summary after surgical treatment with the histology report, as well as an electronic referral for a consultation with a nuclear medicine physician or for planned inpatient treatment.